NAPAAC Program

NAPAAC Logo

The NAPAAC Congress 2022 is an educational event approved as an Accredited Group Learning Activity under Section 1 of the Framework of Continuing Professional Development options as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

As an accredited provider, the CSACI has approved this program.

Through an agreement between the American Medical Association and the Royal College of Physicians and Surgeons of Canada, the CSACI has designated this live educational activity, NAPAAC Congress 2022, for AMA PRA Category 1 Credits™.

View the Speaker COIs

Wed. Sept

21

10:00

Foyer 200 ABC - Registration open

11:00

200 AB - Exhibits open

Grab and Go lunch provided at 11:30 AM

12:00-14:00

Moderator: Dr. Philippe Bégin

200 C: NAPAAC Welcome & Keynote

This session will open the inaugural conference and will highlight the progress that our specialty has made in the field of oral immunotherapy (OIT) for food. We look forward to an exciting debate about whether or not we can now consider OIT this standard of care and hope to learn more about how to prepare our families for this exciting and often challenging endeavor.

Dr. Paul Turner

OIT: What have we learned?
Learning Objectives: At the end of this session, participants will be able to:  

  1. Understand how our knowledge of OIT has evolved over the last 10 years 
  2. Discuss the impact this has had on expected outcomes of OIT 
  3. Identify potential predictors of response to OIT.

Dr. Douglas Mack

Preparing families for their OIT journey
Learning Objectives: At the end of this session, participants will be able to: 

  1. Communicate risks, benefits and expected outcome of oral immunotherapy with families
  2. Provide details surrounding daily dosing regimen and adjustments
  3. Educate families how to monitor for adverse effects

Dr. Arnon Elizur vs Dr. David Stukus

Pro/Con: OIT is the new standard of care
Learning Objectives: At the end of this session, participants will be able to:

  1. Discuss limitations of oral immunotherapy with interested families
  2. Identify ideal candidates based upon clinical history, motivation, and desire for treatment
14:00-14:30

200AB Exhibit Hall: Coffee Break

14:30 – 16:00

ROOM 202: Advanced OIT Breakouts

These interactive sessions will be organized as breakout groups dealing with beginner and advanced aspects of OIT.  The participant is encouraged to consider their own skill set and experience when choosing a stream. Brief presentations will be followed by interactive discussions amongst the audience and experienced OIT providers.

Learning Objectives: At the end of this session, participants will be able to:

  • Tailor oral immunotherapy protocols per individual clinical history and risk tolerance
  • Establish protocols for dose adjustments to address adverse reactions and missed doses of oral immunotherapy

Moderator: Dr. Douglas Mack

Speakers: Dr. Arnon Elizur, Dr. Phillippe Begin, Dr. Aikaterini Anagnostou, Dr. Douglas Mack, Helene Leroux

14:30 – 16:00

ROOM 204: Practical OIT breakouts

These interactive sessions will be organized as breakout groups dealing with beginner and advanced aspects of OIT.  The participant is encouraged to consider their own skill set and experience when choosing a stream. Brief presentations will be followed by interactive discussions amongst the audience and experienced OIT providers.

Learning Objectives: At the end of this session, participants will be able to:

  • Establish clinic workflow to address the time, space, and personnel needed for implementation of oral immunotherapy into practice
  • Prepare families for oral immunotherapy with a thorough discussion of risks, benefits, daily regimen, and expected outcomes

Moderator: Dr. David Stukus

Speakers: Dr. Scott Cameron, Dr. Paul Turner, Dr. David Stukus, Dr. Mariam Hanna

16:00-16:30

200AB Exhibit Hall: Coffee Break

16:30 - 18:00

ROOM 200C: Fireside Chat

 

 

Moderator: Dr. David Stukus

Dr. Aikaterini Anagnostou, Dr. Arnon Elizur, Dr. Paul Turner, Dr. Edwin Kim, Dr. Douglas Mack

This informal fireside chat will highlight multiple key questions affecting our field. The first chat will examine key questions surrounding OIT and how our practice can adapt. Each participant will have two minutes to present their response to the fundamental question and the expert panel will then have an informal debate and discussion about these timely topics.

Learning Objectives: At the end of this session participants will be able to:

  • Identify best candidates for consideration of oral immunotherapy
  • Utilize shared decision making when discussing oral immunotherapy with parents
Miravo Aralez
This session was co-developed with MIRAVO and was planned to achieve scientific integrity, objectivity and balance.  This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by Canadian Society of Allergy and Clinical Immunology.
18:00 - 19:00

ROOM 200AB: Reception

 

Join us for a drink and appetizers

Thurs. Sept

22

7:00 – 7:45

Moderator: Dr. Mariam A. Hanna

ROOM 200C: SLIT Breakfast

 

 

Dr. Edwin Kim

This exciting symposium will discuss the evidence and potential for a very low dose of sublingual immunotherapy for the safe and effective treatment of food allergies.

Learning Objectives: At the end of this session, participants will be able to:

  1. Identify key differences between oral immunotherapy and sublingual immunotherapy
  2. Discuss risks, benefits and expected outcomes of sublingual immunotherapy with families
alk
This session was co-developed with ALK and was planned to achieve scientific integrity, objectivity and balance.  This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by Canadian Society of Allergy and Clinical Immunology.
8:00 – 10:00

Moderator: Dr. Elana Lavine

ROOM 200C: Keynotes

This session will highlight the area of food allergy prevention and current controversies, as well as areas for improvement.  We will also discuss the management of non-IgE mediated food allergy including FPIES and FPIAP and will debate the role of asthma in food allergy outcomes.

 

 

Dr. Elissa Abrams

Food Allergy Prevention: What are we missing?
Learning Objectives: At the end of this session, participants will be able to:

  1. Discuss the evolving evidence surrounding introduction of allergenic foods with families
  2. Proactively address common concerns
  3. Limit unnecessary use of food allergy tests prior to introduction

Dr. Anna Nowak-Wegryzn

The Latest Perspective on FPIES and non-IgE Mediated Food Allergy
Learning Objectives: At the end of this session, participants will be able to:

  1. Diagnose food protein induced enterocolitis syndrome according to guideline based criteria
  2. Discuss reintroduction of suspected foods as children age
  3. Limit unnecessary dietary avoidance for suspected non-IgE mediated food allergy
w

Dr. Aikaterini Anagnostou vs Dr. Paul Turner

Pro/Con: Asthma is a risk factor for food allergy outcomes  
Learning Objectives: At the end of this session, participants will be able to:

  1. Assess asthma control and severity for patients with food allergy
  2. Discuss importance of asthma management for patients with food allergy
10:00-10:30

200AB Exhibit Hall: Coffee Break

10:30-12:00

Moderator: Dr. Anna Nowak-Wegryzn

ROOM 200C: Keynotes

These novel presentations will update you on the key recent articles on food allergy and critically appraise them! As well, the audience will have an opportunity to decide the fate of a patient with eczema, will they eliminate foods, will they introduce foods early, can they prevent allergy? The future of this child is in your hands.

 

 

w

Dr. Moshe Ben Shoshan, Dr. Aikaterini Anagnostou, Dr. Elissa Abrams

The most important articles you haven't read this year…and what's wrong with them
Learning Objectives: At the end of this session, participants will be able to: 

  1. Discuss current evidence based approaches to food allergy management with patients
  2. Adapt clinical practice to reflect evolving evidence surrounding food allergy management

Dr. Matthew Greenhawt

Choose Your Own Adventure: The future of this infant with atopic dermatitis is in your hands
Learning Objectives: At the end of this session, participants will be able to:

  1. Limit use of food allergy tests in infants with atopic dermatitis
  2. Educate families regarding risks of dietary elimination in infants with atopic dermatitis
12:00-12:30

200AB Exhibit Hall: Grab and Go lunch available

12:30-13:00

Moderator: Dr. David Stukus

ROOM 200C: Lunch address

 

 

Dr. Jay Lieberman

Epinephrine - Current use and future strategies

This lunchtime symposium will highlight the current evidence surrounding the use of epinephrine for anaphylaxis, guideline recommendations, options for treatment and future directions.

Learning Objectives: At the end of this session, participants will be able to:

  1. Educate families regarding common misconceptions surrounding epinephrine autoinjectors
  2. Communicate safety and efficacy of epinephrine for treatment of anaphylaxis
  3. Understand pharmacodynamics of epinephrine through various delivery methods
13:15 - 15:00

Moderator: Dr. Moshe Ben-Shoshan

ROOM 200C: Keynotes

This exciting afternoon will highlight the future of the use of Biologics in the management of food allergy, the use of antihistamines and other adjunct medications in the management of food allergy.  It will also highlight the challenges of the use of baked products for patients with egg and milk allergy in the most unique Pro/Con Debate you have ever seen! Rounding out the discussion will be a review of the psychological challenges facing patients and families with allergy.

 

 

Dr. Sharon Chinthrajah

Biologics: Current and Future Applications for Food Allergy Treatment
Learning Objectives: At the end of this session, participants will be able to:

  1. Describe the immunologic mechanisms underlying food allergy reactions
  2. Extrapolate current understanding of biologic therapy for other allergic conditions to use in food allergy
  3. Identify patient characteristics that may make biologics an amenable therapeutic option

Dr. Antonella Muraro

The role of antihistamines and other adjunctive medications in the food allergy treatment plan
Learning Objectives: At the end of this session, participants will be able to:

  1. Discuss hesitancy associated with epinephrine with families
  2. Educate families regarding anaphylaxis management and risk for biphasic reactions
  3. Communicate proper use of antihistamines and adjunctive medications during food allergy reactions
w

Dr. Matthew Greenhawt

1 EXPERT, 2 OPINIONS PRO/CON! 

Food ladders should be offered to all milk and egg allergic children

Learning Objectives: At the end of this session, participants will be able to:

  1. Apply new concepts surrounding risk of reactions from various milk and egg products to clinical recommendations
  2. Educate families regarding variations in allergic potential from various milk and egg products
15:00-15:30

Moderator: Dr. Douglas Mack

ROOM 200C: Anaphylaxis, Anxiety & Angst

 

 

Dr. Elana Lavine

The Role of Psychology in Food Allergy Management
Learning Objectives: At the end of this session, participants will be able to:

  1. Discuss anxiety with families during food allergy encounters
  2. Anticipate common concerns and proactively address with families
  3. Identify families that may benefit from additional psychology services
15:30-16:00

200AB Exhibit Hall: Coffee break

16:00-17:00

ROOM 200C: Fireside Chat

 

 

Moderator: Dr. Douglas Mack

Dr. Matthew Greenhawt, Dr. Elissa Abrams, Dr. Jay Lieberman, Dr. David Stukus

This informal fireside chat will highlight multiple key questions affecting our field.  The second chat will deal with food allergy challenges, research and future directions. Each participant will have two minutes to present their response to the fundamental question and the expert panel will then have an informal debate and discussion about these timely topics.

Learning Objectives: At the end of this session participants will be able to:

  • Perform food allergy testing based upon the clinical history
  • Advise food avoidance based upon evaluation of risk/benefit for each patient
Medexus pharma
This session was co-developed with Medexus and was planned to achieve scientific integrity, objectivity and balance.  This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by Canadian Society of Allergy and Clinical Immunology.